Servier Pharmaceuticals shared on LinkedIn:
“We’re heading to Philadelphia to attend the 2026 Society for Neuro-Oncology Annual Meeting, where we’ll share new and updated data across 9 oral and poster presentations.
We look forward to connecting with the neuro-oncology community to discuss the latest research and our ongoing work to advance the science for people living with glioma.”
About 2026 Society for Neuro-Oncology Annual Meeting
The 31st Annual Meeting nad Education Day of the Society for Neuro-Oncology (SNO) will take place on November 12-15, 2026, in Philadelphia, Pennsylvania, USA.
SNO 2026 is one of the world’s leading scientific conferences dedicated to brain and spinal cord tumors, bringing together more than 3,000 researchers and clinician-scientists from over 40 countries.
Dates: November 12-15, 2026
Venue: Pennsylvania Convention Center, Philadelphia, USA
Organizer: Society for Neuro-Oncology (SNO)
Theme: Crossing the Translational Divide: From Neurons to Novel Therapie
Main Scientific Focus
The meeting aims to connect discoveries in basic neuroscience and tumor biology with new approaches to diagnosing and treating brain tumors.
Key Areas Include:
- Glioma and glioblastoma: Emerging treatment strategies and ongoing clinical research.
- Molecular diagnostics and biomarkers: Improving tumor classification and personalized treatment decisions.
- Targeted therapies and immunotherapy: Investigating novel therapeutic approaches.
- Artificial intelligence: Applications in neuro-oncology research and clinical care.
- Drug delivery: New strategies for delivering treatments to the central nervous system.
- Translational research: Bringing laboratory discoveries closer to clinical practice.
Stay informed about the latest news and updates from Servier, Servier Pharmaceuticals through our related coverage on OncoDaily.